Remove trial restrictions ▶ Start for $1

Serving leading biopharmaceutical companies globally:

Last Updated: May 27, 2022

Shire Company Profile

✉ Email this page to a colleague

« Back to Dashboard

What is the competitive landscape for SHIRE, and what generic and branded alternatives to SHIRE drugs are available?

SHIRE has twenty-five approved drugs.

Summary for Shire

US Patents:	0
Tradenames:	18
Ingredients:	16
NDAs:	25
Patent Litigation for Shire:	See patent lawsuits for Shire
PTAB Cases with Shire as patent owner:	See PTAB cases with Shire as patent owner

Drugs and US Patents for Shire

+ Get email alerts for changes to this table

Subscribe to access the full database, or Try it Free
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Shire	PRO-BANTHINE	propantheline bromide	TABLET;ORAL	008732-003	Approved Prior to Jan 1, 1982		DISCN	Yes	No		See Plans and Pricing				See Plans and Pricing
Shire Richwood	X-TROZINE	phendimetrazine tartrate	TABLET;ORAL	086551-001	Approved Prior to Jan 1, 1982		DISCN	No	No		See Plans and Pricing				See Plans and Pricing
Shire	PRO-BANTHINE	propantheline bromide	TABLET;ORAL	008732-002	Approved Prior to Jan 1, 1982		DISCN	Yes	No		See Plans and Pricing				See Plans and Pricing
Shire Richwood	OBY-TRIM	phentermine hydrochloride	CAPSULE;ORAL	087764-001	Mar 18, 1982		DISCN	No	No		See Plans and Pricing				See Plans and Pricing
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>TE	>Type	>RLD	>RS	>Patent No.	>Patent Expiration	>Product	>Substance	>Delist Req.	>Exclusivity Expiration

Expired US Patents for Shire

Subscribe to access the full database, or Try it Free
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	Patent No.	Patent Expiration
Shire	ETHMOZINE	moricizine hydrochloride	TABLET;ORAL	019753-002	Jun 19, 1990	3,864,487	See Plans and Pricing
Shire	SUPPRELIN	histrelin acetate	INJECTABLE;INJECTION	019836-003	Dec 24, 1991	4,244,946	See Plans and Pricing
Shire	SUPPRELIN	histrelin acetate	INJECTABLE;INJECTION	019836-001	Dec 24, 1991	4,244,946	See Plans and Pricing
Shire	ETHMOZINE	moricizine hydrochloride	TABLET;ORAL	019753-002	Jun 19, 1990	3,740,395	See Plans and Pricing
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>Patent No.	>Patent Expiration

Paragraph IV (Patent) Challenges for SHIRE drugs

Drugname	Dosage	Strength	Tradename	Submissiondate
➤ Subscribe	Injection	10 mg/mL	➤ Subscribe	2015-08-25

Similar Applicant Names

Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Merck

Moodys

Dow

AstraZeneca

McKesson

Express Scripts

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.